CNBX (CNBX Pharmaceuticals) Float Percentage Of Total Shares Outstanding: 99.95% (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CNBX Pharmaceuticals Float Percentage Of Total Shares Outstanding?

CNBX Pharmaceuticals CNBX +33.33% Float Percentage Of Total Shares Outstanding is 99.95% as of Aug. 27, 2026. The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, CNBX Pharmaceuticals's float shares is 1,605.04 Mil. CNBX Pharmaceuticals's total shares outstanding is 1,605.77 Mil. CNBX Pharmaceuticals's float percentage of total shares outstanding is 99.95%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, CNBX Pharmaceuticals's Insider Ownership is 73.51%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, CNBX Pharmaceuticals's Institutional Ownership is 0.00%.

CNBX Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

CNBX Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=1,605.04/1,605.77
=99.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.95% mean?
CNBX Pharmaceuticals (CNBX) has a Float Percentage Of Total Shares Outstanding of 99.95% as of Aug. 27, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on CNBX Pharmaceuticals and its competitors.
Is CNBX Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
CNBX Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 99.95%.
How does CNBX Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to SIGY and LIPO?
CNBX Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 99.95% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on CNBX Pharmaceuticals and its competitors. CNBX Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 99.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNBX Pharmaceuticals stock overvalued right now?
CNBX Pharmaceuticals (CNBX) has a current Float Percentage Of Total Shares Outstanding of 99.95%. The current Float Percentage Of Total Shares Outstanding is 99.95%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For CNBX Pharmaceuticals (CNBX), the current Float Percentage Of Total Shares Outstanding is 99.95% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CNBX Pharmaceuticals Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.